摘要
目的探讨对高龄冠心病合并心力衰竭患者使用新活素的临床效果。方法方便选取该院高龄冠心病合并心力衰竭患者80例(2013年11月—2015年10月期间),将其单双号编号分2组,40例为一组。对照组给予常规临床治疗,观察组再辅以新活素,对比2组效果。结果观察组LVEF平均值(47.62±9.01)%、NT-pro BNP平均值(2 495.62±287.62)ng/L优于对照组,P<0.05,差异有统计学意义,但对比2组不良反应概率差别不大差异无统计学意义(P>0.05)。结论新活素用于治疗高龄冠心病合并心力衰竭患者的效果可观。
Objective To observe the effect of using new living elements in coronary heart disease complicated with heart failure. Methods Convenient selected 80 cases of elderly patients with coronary heart disease complicated with heart failure （Novermber 2013 to October 2015）, divided into 2 groups, the control group was given conventional treatment, the observa-tion group was supplemented with new living elements, compared with 2 groups of effects. Results Observation group LVEF average （47.62±9.01）%, NT-proBNP average （2 495.62±287.62） ng/L than the control group, P〈0.05, the difference is sta-tistically significant but the contrast between the 2 groups of adverse reaction probability difference （P〉0.05）. Conclusion The effect of new active element in the treatment of elderly patients with coronary heart disease and heart failure.
出处
《中外医疗》
2016年第19期148-149,共2页
China & Foreign Medical Treatment
关键词
高龄
冠心病
心力衰竭
新活素
Old age
Coronary heart disease
Heart failure
New living element
